Xenon Pharmaceuticals (XENE) EPS (2014 - 2026)
Xenon Pharmaceuticals (XENE) EPS from Mar 31, 2014 to Mar 31, 2026. The TTM Xenon Pharmaceuticals (XENE) EPS is -$4.65. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Xenon Pharmaceuticals (XENE) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +40.91% |
| 3 Years TTM | +25.52% |
| 5 Years TTM | +48.59% |
| 10 Years TTM | +27.46% |
Annual EPS change of Xenon Pharmaceuticals (XENE)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$1.06 | -75.51% |
| 2025 | -$4.32 | +40.98% |
| 2024 | -$3.07 | +26.72% |
| 2023 | -$2.42 | +20.81% |
| 2022 | -$2.00 | +31.12% |
| 2021 | -$1.53 | +85.46% |
| 2020 | -$0.82 | -44.27% |
| 2019 | -$1.48 | +10.32% |
| 2018 | -$1.34 | -21.45% |
| 2017 | -$1.71 | +32.98% |
| 2016 | -$1.28 | +17.16% |
| 2015 | -$1.09 | -219.25% |
| 2014 | $0.92 | -50.13% |
| 2013 | $1.84 | -376.20% |
| 2012 | -$0.67 | N/A |
Comparison Xenon Pharmaceuticals (XENE) five years EPS CAGR with competitors
Xenon Pharmaceuticals (XENE) five years EPS CAGR is 40.27%.